Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 15, 2020
Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptorKouji Fukuyama, Masashi Fukuzawa, Takashi Shiroyama, et al.
British Journal of Pharmacology|November 28, 2025
Exploring effects of chronic d-cycloserine administration on expression of GluN2 subunits and tripartite synaptic transmission in thalamocortical pathwayMotohiro Okada, Ruri Okubo, Nobutomo Yamamoto, et al.
JAMA Network Open|August 7, 2023
Suicidal Mortality and Motives Among Middle-School, High-School, and University StudentsMotohiro Okada, Ryusuke Matsumoto, Takashi Shiroyama, et al.
Epilepsia|October 18, 2002
Molecular genetics of human familial epilepsy syndromesShinichi Hirose, Motohiro Okada, Sunao Kaneko, et al.
Biomolecules|November 23, 2019
Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical TransmissionsMotohiro Okada, Kouji Fukuyama, Tomosuke Nakano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 11, 2021
Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle proteinMotohiro Okada, Kouji Fukuyama, Takashi Shiroyama, et al.
International Journal of Molecular Sciences|February 12, 2021
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 ReceptorMotohiro Okada, Ryusuke Matsumoto, Yoshimasa Yamamoto, et al.
International Journal of Molecular Sciences|April 30, 2021
Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic TransmissionsKouji Fukuyama, Tomosuke Nakano, Takashi Shiroyama, et al.
Pageof 20